Reproductive capacity in iron overloaded women with thalassemia major

Blood

Volumn 118, Issue 10, 2011, Pages 2878-2881

  Singer, Sylvia T ^a   Vichinsky, Elliott P ^a   Gildengorin, Ginny ^a   Van Disseldorp, Jereon ^b   Rosen, Mitchell ^c   Cedars, Marcelle I ^c  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; MUELLERIAN INHIBITING FACTOR; NONTRANSFERRIN BOUND IRON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FEMALE INFERTILITY; GONADOTROPIN RELEASE; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; IRON CHELATION; IRON OVERLOAD; ORGAN SIZE; OVARY FOLLICLE; OVARY FOLLICLE COUNT; OVARY VOLUME; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; REPRODUCTION; REPRODUCTIVE CAPACITY; THALASSEMIA MAJOR;

EID: 80052685808     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-360271     Document Type: Article

References (25)

1. Al-Rimawi HS, Jallad MF, Amarin ZO, Obeidat BR. Hypothalamic-pituitary- gonadal function in adolescent females with beta-thalassemia major. Int J Gynaecol Obstet. 2005;90(1):44-47. (Pubitemid 40909956)
2. Skordis N, Petrikkos L, Toumba M, et al. Update on fertility in thalassaemia major. Pediatr Endocrinol Rev. 2004;2(suppl 2):296-302.
3. Bergeron C, Kovacs K. Pituitary siderosis: a histologic, immunocytologic, and ultrastructural study. Am J Pathol. 1978;93(2):295-309. (Pubitemid 9047343)
4. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685-718. (Pubitemid 44605509)
5. Kwee J, Schats R, McDonnell J, Themmen A, De Jong F, Lambalk C. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril. 2008;90(3):737-743.
6. Sills ES, Alper MM, Walsh AP. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):30-36.
7. Scheffer GJ, Broekmans FJ, Looman CW, et al. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod. 2003;18(4):700-706. (Pubitemid 36426945)
8. Knauff EA, Eijkemans MJ, Lambalk CB, et al. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009;94(3):786-792.
9. Papadimas J, Goulis DG, Mandala E, et al. Beta-thalassemia and gonadal axis: a cross-sectional, clinical study in a Greek population. Hormones (Athens). 2002;1(3):179-187.
10. Telfer P. Update on survival in thalassemia major. Hemoglobin. 2009;33(suppl 1):S76-S80.
11. Borgna-Pignatti C. The life of patients with thalassemia major. Haematologica. 2010;95(3):345-348.
12. Rosen MP, Sternfeld B, Schuh-Huerta SM, Reijo Pera RA, McCulloch CE, Cedars MI. Antral follicle count: absence of significant midlife decline. Fertil Steril. 2010;94(6):2182-2185.
13. Origa R, Piga A, Quarta G, et al. Pregnancy and beta-thalassemia: an Italian multicenter experience. Haematologica. 2010;95(3):376-381.
14. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008;93(9):3478-3483.
15. Van Disseldorp J, Faddy MJ, Themmen AP, et al. Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab. 2008;93(6):2129-2134. (Pubitemid 351831526)
16. Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19(9):340-347.
17. Oppermann K, Fuchs SC, Spritzer PM. Ovarian volume in pre- and perimenopausal women: a population-based study. Menopause. 2003;10(3):209-213. (Pubitemid 36706304)
18. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18(2):277-287. (Pubitemid 40298370)
19. Tarin JJ. Potential effects of age-associated oxidative stress on mammalian oocytes/embryos. Mol Hum Reprod. 1996;2(10):717-724. (Pubitemid 126717522)
20. Reubinoff BE, Har-El R, Kitrossky N, et al. Increased levels of redox-active iron in follicular fluid: a possible cause of free radical-mediated infertility in beta-thalassemia major. Am J Obstet Gynecol. 1996;174(3):914-918. (Pubitemid 26111670)
21. Luck MR, Jeyaseelan I, Scholes RA. Ascorbic acid and fertility. Biol Reprod. 1995;52(2):262-266.
22. Piga A, Longo F, Duca L, et al. High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol. 2009;84(1):29-33.
23. Britton RS, Leicester KL, Bacon BR. Iron toxicity and chelation therapy. Int J Hematol. 2002;76(3):219-228. (Pubitemid 43020310)
24. Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood. 1996;88(9):3608-3614. (Pubitemid 26365599)
25. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood. 2003;102(7):2670-2677. (Pubitemid 37193611)